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Feltri et al. (2001, this issue) succeed in disrupting 
 
 
 
1
integrin speciﬁcally in Schwann cells, and in so doing,
demonstrate that it is required for normal myelination.
Their results reveal that signaling by an extracellular
matrix receptor plays a key role in the differentiation of
myelinating Schwann cells.
 
A series of interactions between axons and Schwann cells
govern peripheral nerve development (Mirsky and Jessen,
1999). Axonally derived neuregulin-1 is required for the sur-
vival and proliferation of Schwann cell precursors, which, in
turn, are required for the survival of neurons. As Schwann
cell precursors develop into immature Schwann cells, they
surround large bundles of axons and become polarized—the
 
inside facing the axons, the outside depositing a basal lamina.
 
Beginning at this time, and extending for many days thereafter,
sheet-like Schwann processes infiltrate these axonal bundles,
separating them into ever smaller bundles, and some axons are
individually ensheathed (Webster, 1993). The promyelinating
Schwann cells, the ones ensheathing axons in a 1:1 manner,
subsequently form a myelin sheath within a few days. Unlike
the Schwann cells that surround axonal bundles, promyelinat-
ing and myelinating Schwann cells are completely surrounded
by a basal lamina. In this way, axons that are destined to be
myelinated acquire the proper complement of Schwann cells,
whereas nonmyelinated axons remain associated with cords of
nonmyelinating Schwann cells.
 
A role for the basal lamina in axonal ensheathment and
 
myelination has long been suspected (Bunge, 1993). The
 
genetic evidence is based on the analysis of 
 
dystrophic
 
 mice
and humans with congenital muscular dystrophy (CMD);*
 
both have mutations in the laminin 
 
 
 
2 gene (Pegoraro et al.,
1998; Xu et al., 1994), resulting in a lack of laminin-2 (the
 
 
 
2
 
 
 
1
 
 
 
1 isoform). 
 
Lama2/LAMA2
 
 mutations cause muscular
dystrophy because laminin-2 is a ligand for dystroglycan, an
essential extracellular matrix receptor expressed by skeletal
muscle cells. Although myopathy predominates the clinical
picture, some CMD patients have abnormal nerve conduction
velocities, indicating that myelination is affected, too.
 
Schwann cells express dystroglycan and even several sar-
 
coglycans (Imamura et al., 2000), but the molecular basis of
the neuropathy in CMD patients is not known. The finding
 
that the ventral roots of adult 
 
dystrophic
 
 mice contain bundles
of unensheathed axons—the persistence of an embryonic
phenotype—provides an important clue in this regard.
Despite the known role of laminin-2 in myelination, its
receptor and mechanism of action have not been previously
elucidated. The report of Feltri et al. (2001) provides important
insights into these issues. They conditionally deleted the gene
 
encoding integrin 
 
 
 
1, a component of laminin receptors, in
 
immature Schwann cells (
 
 
 
1 integrin was absent by E17.5),
before the formation of promyelinating Schwann cells, and
 
found that myelination is markedly delayed. This delay
results from the failure of Schwann cells both to subdivide
bundles of axons and to progress past the promyelinating
stage. Furthermore, the cell membrane of “arrested” pro-
myelinating Schwann cells frequently fails to appose the
basal lamina and even retracts, leaving the axon unen-
sheathed. The myelinated axons that do arise, albeit belatedly,
appear normal. These anatomical abnormalities likely pre-
clude saltatory conduction and lead to the development
of a progressive peripheral neuropathy. Thus, immature
 
Schwann cells require 
 
 
 
1 integrin to properly segregate
bundled axons during development, and promyelinating
Schwann cells may require 
 
 
 
1 integrin to adhere to their
basal laminae and initiate the formation of a myelin
sheath. The earlier observation that antibodies against 
 
 
 
1
integrin interfere with myelination in vitro (Fernandez-Valle
et al., 1994) is elegantly confirmed and extended.
The findings of Feltri et al. (2001) suggest that the receptor
for laminin-2 switches during development. As depicted in
Fig. 1, immature and promyelinating Schwann cells express
 
 
 
6
 
 
 
1 integrin, whereas myelinating Schwann cells predomi-
 
nately express 
 
 
 
6
 
 
 
4 integrin (Previtali et al., 2001). In epithe-
lial cells, 
 
 
 
6
 
 
 
4 integrin links the basal lamina to intermediate
filaments via hemidesmosomes, whereas Schwann cells do
not have hemidesmosomes. Thus, 
 
 
 
6
 
 
 
4 may be linked to
the actin cytoskeleton rather than to intermediate filaments.
Although dystroglycan appears to be expressed on both
promyelinating and myelinating Schwann cells, only the
latter express a protein that interacts with dystroglycan,
dystroglycan-related protein 2 (DRP2), as well as a protein
that interacts with DRP2, periaxin (Sherman et al., 2001).
Dystroglycan, DRP2, and periaxin form a macromolecular
 
Address correspondence to S.S. Scherer, The University of Pennsylvania
Medical Center, Room 460 Stemmler Hall, 36th Street and Hamilton
Walk, Philadelphia, PA 19104-6077. Tel.: (215) 573-3198. Fax: (215)
573-4454. E-mail: sscherer@mail.med.upenn.edu
*Abbreviations used in this paper: CMD, congenital muscular dystrophy;
DRP2, dystroglycan-related protein 2. 
14 The Journal of Cell Biology 
 
|
 
 
 
Volume 156, Number 1, 2002
 
complex with utrophin, Dp116 (an isoform of dystrophin
expressed in Schwann cells), and the actin cytoskeleton. One
of these components, periaxin, is essential for the stability of
myelin sheaths, as mice and humans lacking periaxin de-
velop a demyelinating peripheral neuropathy (Boerkoel et
al., 2000; Gillespie et al., 2000; Guilbot et al., 2001). These
results suggest that one set of extracellular matrix receptors is
required to initiate the formation of the myelin sheath, and
another set is required to maintain it.
The developmental switching of laminin-2 receptors also
provides a possible explanation for the belated myelination
in mice lacking 
 
 
 
1 integrin. The two potential candidates,
dystroglycan and 
 
 
 
6
 
 
 
4 integrin, appear about the day of
birth and are expressed by myelinating Schwann cells in
wild-type and in 
 
 
 
1 integrin–null mice (Feltri et al., 2001).
Perhaps the 
 
 
 
1-deficient promyelinating Schwann cells that
finally form myelin sheaths can do so because they express
 
one of these receptors. It also seems plausible that laminin-2
is not the only ligand for 
 
 
 
1 integrin that is relevant for my-
elination, as myelination is more disrupted in mice lacking
 
 
 
1 integrin than in mice lacking laminin-2. This discrep-
ancy may owe to the versatility of 
 
 
 
1 integrin, which has a
potentially diverse number of ligands, because it can form
heterodimers with a large number of 
 
 
 
 subunits.
Based on the phenotype of 
 
 
 
1 integrin–null mice, Feltri et
al. (2001) suggest that the loss of 
 
 
 
1 integrin-mediated ad-
hesion to laminin-2 in Schwann cells contributes to the phe-
notype of CMD caused by 
 
LAMA2
 
 mutations. Peripheral
neuropathy likely contributes to the phenotype, as express-
ing wild-type laminin 
 
 
 
2 in skeletal muscle of 
 
dystrophic
 
mice does not completely reverse hindlimb weakness (Kuang
et al., 1998). In the absence of 
 
 
 
1 integrin or laminin-2, im-
mature Schwann cells cannot reorganize their cytoskeleton
as required to generate the membrane sheets that segregate
axonal bundles. Furthermore, promyelinating Schwann cells
lacking 
 
 
 
1 integrin do not properly adhere to their basal
lamina and thus may lack critical signals that are required to
form a myelin sheath.
In summary, although the anatomical aspects of myelina-
tion have been known for decades, its molecular underpin-
nings are only now emerging. Feltri et al. (2001) provide
conclusive evidence that signaling through 
 
 
 
1 integrin is es-
sential for the first steps of axonal ensheathment. These find-
ings illuminate the earlier observations that axons are re-
quired for Schwann cells to assemble a basal lamina, and that
a basal lamina is required for myelination (Bunge, 1993).
Together, these results indicate that reciprocal interactions
govern axonal ensheathment. Axons enable Schwann cells to
form a basal lamina, which in turn, enables Schwann cells to
interact properly with axons; in both cases, signals originat-
ing from one side of the Schwann cell affect the opposite
side. How receptor-mediated signaling initiates and main-
tains the myelin sheath, one of the most spectacular struc-
tures in cell biology, is surely a problem worth unwrapping.
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Myelinating Schwann cells express  6 4 in addition to  6 1, 
and dystroglycan interacts with periaxin (depicted as a dimmer) 
via DRP2 (B). 
Myelination: some receptors required |
 
 Scherer 15
Kuang, W., H. Xu, P.H. Vachon, L. Liu, F. Loechel, U.M. Wewer, and E. Engvall.
1998. Merosin-deficient congenital muscular dystrophy - Partial genetic cor-
rection in two mouse models. 
 
J. Clin. Invest.
 
 102:844–852.
Mirsky, R., and K.R. Jessen. 1999. The neurobiology of Schwann cells. 
 
Brain
Pathol.
 
 9:293–311.
Pegoraro, E., H. Marks, C.A. Garcia, T. Crawford, P. Mancias, A.M. Connolly,
M. Fanin, F. Martinello, C.P. Trevisan, C. Angelini, et al. 1998. Laminin
 
 
 
2 muscular dystrophy: Genotype/phenotype studies of 22 patients. 
 
Neurol-
ogy.
 
 51:101–110.
Previtali, S.C., M.L. Feltri, J.J. Archelos, A. Quattrini, L. Wrabetz, and H.P. Har-
tung. 2001. Role of integrins in the peripheral nervous system. 
 
Prog. Neuro-
 
biol.
 
 64:35–49.
Sherman, D.L., C. Fabrizi, C.S. Gillespie, and P.J. Brophy. 2001. Specific disrup-
tion of a Schwann cell dystrophin-related protein complex in a demyelinat-
ing neuropathy. 
 
Neuron.
 
 30:677–687.
Webster. H.d. 1993. Development of peripheral nerve fibers. 
 
In
 
 Peripheral Neu-
ropathy. Vol. 1. P.J. Dyck, P.K. Thomas, P.A. Low, and J.F. Poduslo, edi-
tors. W.B. Saunders, Philadelphia. 243–266.
Xu, H., X.-R. Wu, U.M. Wewer, and E. Engvall. 1994. Murine muscular dystro-
phy caused by a mutation in the laminin 
 
 
 
2 (
 
Lama2
 
) gene. 
 
Nat. Genet.
 
8:297–302.